• Bm|t-backed SmartDyeLivery raised a private financing round in the millions to fund its next growth phase.
• The company is developing a platform focused on pharmaceutical active ingredients, supported by fresh capital and an expanded shareholder base.
• bm|t portfolio company neurocare raised EUR 2 million in private financing to support its personalized digital therapies and non-invasive neurotechnology platform.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bm T Beteiligungsmanagement published the original content used to generate this news brief on July 13, 2026, and is solely responsible for the information contained therein.